Delivery Order 75N93023D00015-75N93026F00002

The National Institute of Allergy and Infectious Diseases issued a delivery order to Advanced Bioscience Laboratories, Inc., on September 6, 2017, with a ceiling value of $110,115.92 under the Preclinical Services for Biopharmaceutical Product Development IDIQ. Place of performance is Rockville, MD. The order was initially set to run through February 10, 2018 and was extended to April 13, 2018 at no additional cost. Pricing is cost plus fixed fee. No set-aside was used for this order.

<p>The National Institute of Allergy and Infectious Diseases issued a delivery order to Advanced Bioscience Laboratories, Inc. on May 2, 2014, for NIAID preclinical development support — SVEU database rewrite, with a ceiling value of $526,079.33.</p> <p>The order is priced on a cost-plus-fixed-fee basis. Place of performance is Rockville, MD. The ultimate completion date is April 30, 2016. No set-aside was used for this delivery order.</p>

The National Institute of Allergy and Infectious Diseases issued a delivery order to Advanced Bioscience Laboratories, Inc. on September 19, 2016, with a ceiling value of $1,469,410.09 for preclinical development support including production feasibility evaluation of technology to modulate protein expression in cellular pathways. Place of performance is Rockville, MD. The order is priced on a cost-plus-fixed-fee basis with an ultimate completion date of September 30, 2019. No set-aside was...

<p>The National Institute of Allergy and Infectious Diseases issued a delivery order to Advanced Bioscience Laboratories, Inc. on September 26, 2014, with a ceiling value of $280,028.24 for preclinical development support including production of GEO-D02 master and working cell banks.</p> <p>Place of performance is Rockville, MD. The order carries an ultimate completion date of September 25, 2017. Pricing is Cost Plus Fixed Fee with no set-aside designation.</p>

<p>The National Institute of Allergy and Infectious Diseases issued a delivery order to Advanced Bioscience Laboratories, Inc. on August 29, 2011, with an obligated amount of $1,996,916 and a ceiling value of $12.2 million under task order HHSN27200001 for Essential Core Activities.</p> <p>Place of performance is Rockville, MD. The order is priced on a cost-plus-fixed-fee basis with an ultimate completion date of August 28, 2017. No set-aside was used.</p>

<p>The National Institute of Allergy and Infectious Diseases issued a delivery order to Advanced Bioscience Laboratories, Inc. with a ceiling value of $255,094.89 on April 10, 2014, for requalification audits of cGMP/GLP facilities supporting NIAID preclinical development.</p> <p>Place of performance is Rockville, MD. The order is priced on a cost-plus-fixed-fee basis and is scheduled for ultimate completion on December 31, 2015.</p>

<p>The National Institute of Allergy and Infectious Diseases issued a delivery order to Advanced Bioscience Laboratories, Inc. on March 6, 2017, with a ceiling value of $186,316.03 for manufacture and characterization services for vaccines and other biologics under contract 1200005I.</p> <p>Place of performance is Rockville, MD. The order is priced on a cost-plus-fixed-fee basis with an ultimate completion date of March 19, 2018. No set-aside was used.</p>

<p>The National Institute of Allergy and Infectious Diseases issued a delivery order to Advanced Bioscience Laboratories, Inc. on September 25, 2014, with a ceiling value of $494,513.97, for preclinical development support including expression and production of HIV-1 envelope protein.</p> <p>Place of performance is Rockville, MD. The delivery order is priced on a cost-plus-fixed-fee basis with an ultimate completion date of September 25, 2017. No set-aside was used.</p>

The National Institute of Allergy and Infectious Diseases issued a delivery order to Advanced Bioscience Laboratories, Inc. on June 10, 2017, with a ceiling value of $2,099,764 for preclinical development support under the Essential Core Activities III program. Place of performance is Rockville, MD. The order is priced as cost-plus-fixed-fee and runs through June 8, 2029. Advanced Bioscience Laboratories provides contract research and manufacturing services specializing in gene therapies,...

The National Institute of Allergy and Infectious Diseases issued a delivery order to Advanced Bioscience Laboratories, Inc. on November 30, 2016, under the HIV Microbicides and Biomedical Prevention 2016–2021 IDIQ, with a ceiling value of $530,845.56 for material receipt, storage, shipping, and inventory services. Place of performance is Rockville, Maryland. The order was priced on a cost-plus-fixed-fee basis with an ultimate completion date of July 14, 2023. No set-aside was used.